000			01598 a2200409 4500
005			20250518083536.0
264		0	_c20201030
008			202010s 0 0 eng d
022			_a1466-609X
024	7		_a10.1186/s13054-020-2743-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aBusse, Laurence W
245	0	0	_aVasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. _h[electronic resource]
260			_bCritical care (London, England) _c02 2020
300			_a36 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAngiotensin II _xtherapeutic use
650	0	4	_aAscorbic Acid _xtherapeutic use
650	0	4	_aCardiac Surgical Procedures _xadverse effects
650	0	4	_aDopamine _xtherapeutic use
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aEpinephrine _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aMethylene Blue _xtherapeutic use
650	0	4	_aNorepinephrine _xtherapeutic use
650	0	4	_aPhenylephrine _xtherapeutic use
650	0	4	_aSympathomimetics _xtherapeutic use
650	0	4	_aVascular Resistance _xdrug effects
650	0	4	_aVasoconstrictor Agents _xtherapeutic use
650	0	4	_aVasoplegia _xdrug therapy
650	0	4	_aVasopressins _xtherapeutic use
700	1		_aBarker, Nicholas
700	1		_aPetersen, Christopher
773	0		_tCritical care (London, England) _gvol. 24 _gno. 1 _gp. 36
856	4	0	_uhttps://doi.org/10.1186/s13054-020-2743-8 _zAvailable from publisher's website
999			_c30596740 _d30596740